 |
L-2-oxothiazolidine-4-carboxylic acid |
|---|---|
| Trade Name | Procysteine |
| Orphan Indication | Amyotrophic lateral sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 1996-07-30 00:00:00 |
| Sponsor | Transcend Therapeutics, Inc.;640 Memorial Drive, 3rd Floor West;Cambridge, Massachusetts, 02139 |
